Sign inJoin waitlistJoin the waitlist

David Wald

Co-Leader, Immune Oncology Program · Case Comprehensive Cancer Center

Credentials: · · · · ·

History

Immune Oncology Program · Case Comprehensive Cancer Center
Present
Immune Oncology Program · Case Western Reserve University
Present
Case Western Reserve University School of Medicine
Present

Chemical Pathology
2008–2009
Pathology
Case Western Reserve University/University Hospitals Cleveland Medical Center
2005–2008
Case Western Reserve University School of Medicine
2001–2005
Case Western Reserve University
1997–2001
Cornell University
1997

Research

SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
Nature Immunology · 2003 · First of 10 authors · 472 citations
The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis
Immunity · 2007 · 268 citations
TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration
Science · 2015 · 261 citations

Marcos de Lima
17 papers
Paolo Caimi
10 papers
Folashade Otegbeye
7 papers · 1 as a fellow
William Tse
7 papers
Yogen Saunthararajah
7 papers
Brenda Cooper
5 papers
James Ignatz-Hoover
5 papers · 2 as a resident
Masumi Oshima
5 papers · 1 as a fellow
Stanton Gerson
5 papers
Grace Begnell
4 papers · 1 as a resident
Hillard Lazarus
4 papers
AG
Abigail Glick
3 papers